waypointjobs

Kyverna

Safety Writer/Scientist – Contract

Remote — United States (see country and timezone requirements)

Check who can apply and the requirements below before continuing.

Job description

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.

Position Overview

Kyverna is seeking a Contract Safety Writer/Scientist – Pharmacovigilance (Consultant) with deep expertise in Safety/Pharmacovigilance to support critical regulatory and medical safety documentation activities. This individual will play a key role in preparing high-quality safety regulatory documents, such as drafting responses to FDA clinical or postmarket Information Requests (IRs), supporting external advisory committee meetings, safety related clinical and medical inquiries, etc. The ideal candidate combines strong scientific writing skills with hands-on experience translating complex safety analyses into clear, regulatory-compliant documentation.

Title: Safety Writer/Scientist – Contract

Location: Remote eligible

Hourly Rate: $170/hr - $190/hr

Duration: 6+ months (20-30 hours per week)

Responsibilities

Author comprehensive safety assessment reports (including signal evaluations), ensuring scientific accuracy, clarity, and regulatory alignment

Prepare and draft high-quality responses to FDA Information Requests as needed

Prepare and draft core safety reference information or justification for safety sections of the label

Prepare and draft slides for safety related presentations for both internal and external meetings, including FDA advisory committee meeting.

Collaborate with cross-functional teams to ensure consistency and completeness of safety narratives and analyses

Contribute to risk-benefit analyses, RMP writing, and other safety sections required for various clinical and safety documents (IB, CSR, etc)

Assist in drafting, editing, formatting, and maintaining safety-related SOPs and associated work instructions

Ensure SOPs align with current regulatory requirements and internal quality standards

Support inspection readiness activities as needed

Qualifications

Advanced degree in life sciences, pharmacy, nursing, public health, or related scientific field (doctorate level preferred)

8+ years of medical writing/safety scientist experience, with significant focus in safety, clinical, or regulatory documents.

Experience with writing safety signal assessment documents.

Prior experience with writing and preparation for FDA advisory committees is highly valued.

Demonstrated experience drafting responses to FDA Information Requests related to safety

Strong understanding of pharmacovigilance principles, including adverse event reporting, signal detection, and risk management

Proven ability to review and interpret adverse event data

Familiarity with global regulatory requirements (EMA, PMDA, etc.)

Originally posted on Himalayas

Who can apply

Eligible countries: United States. Accepted UTC offsets: UTC-10, UTC-9, UTC-8, UTC-7, UTC-6, UTC-5, UTC+14. Review the full description for employer-specific work authorization, residency and schedule requirements.

Ready for your next step?Apply on the official website
Apply on Himalayas ↗

Explore related searches

Current related jobs

Juniper Square

Jobicy

Account Executive, Private Equity

Remote — USA

Salary not specifiedRemote

About Juniper Square Private markets are one of the largest, most complex, and most underserved corners of global finance. Our mission at Junipe…

Last received from source 2026-10-10View job

1Password

Jobicy

Principal Engineer, Product Engineering

Remote — Canada, USA

Salary not specifiedRemote

1Password is growing. We’ve surpassed $400M in ARR and we’re continuing to accelerate, earning a spot on the Forbes Cloud 100 for four years in a…

Last received from source 2026-10-10View job